secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001437749-26-015039
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences expands ATM to allow insider purchases; major holder and CEO indicate likely buying
--------------------------------------------------------------------------------

- Board authorized TD Cowen to sell shares to affiliates under existing ATM with up to $60M aggregate offering.
- Robert Duggan (72% owner) and CEO Paul LaViolette indicate they are likely to purchase shares in near term.
- No binding commitments or share counts; purchases would be at prevailing market bid or better.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926015039/0001437749-26-015039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926015039/plse20260505_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-015039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer